SavedAdd your journal

Journals / Van Tıp Dergisi / 2014 / Cilt: 21 - Sayı: 4

A Rare Complication of Intravesikal BCG Instillation Which Can Be Confused with Tumour: Granulomatous Orchitis

İntravezikal BCG Tedavisi Sonrası Görülen ve Tümör ile Karışabilen Nadir Bir Komplikasyon: Granülomatöz Orşit

Serhan ÇİMEN
Ramazan ALTINTAŞ
Cemal TAŞDEMİR
Adile Ferda DAĞLI
Pages
239–241
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although the mechanism of effect of BCG is unclear, that is known to delay tumor progression, to decrease the need for cystectomy and to increase overall survival via stimulating various local immune responses and having antitumor activity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intravesical Bacillus Calmette-Gue'rin instillations have been used in treatment of carcinoma in situ and superficial tumor of bladder.
📊
Key Findings & Data:Although the mechanism of effect of BCG is unclear, that is known to delay tumor progression, to decrease the need for cystectomy and to increase overall survival via stimulating various local immune responses and having antitumor activity.
💡
Conclusion & Impact:In this report, which is a rare complication of intravesical BCG treatment, we presented the case of granulomatous orchitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Intravesical Bacillus Calmette-Gue'rin instillations have been used in treatment of carcinoma in situ and superficial tumor of bladder. Although the mechanism of effect of BCG is unclear, that is known to delay tumor progression, to decrease the need for cystectomy and to increase overall survival via stimulating various local immune responses and having antitumor activity. While it is generally well tolerated, it has rare side effects. In this report, which is a rare complication of intravesical BCG treatment, we presented the case of granulomatous orchitis.

Özet

İntravezikal Bacillus Calmette-Gue'rin (BCG) uygulaması karsinoma in situ ve yüzeyel mesane tümörü tedavisinde kullanılmaktadır. Etki mekanizması belirsiz olmakla beraber çeşitli lokal immun yanıtları tetiklediği ve antitümör aktivitesi göstererek tümör progresyonunu geciktirdiği, sistektomi ihtiyacını azalttığı ve genel sağkalımı arttırdığı bilinmektedir. Genel olarak iyi tolere edilmekle birlikte nadir yan etkilere sahiptir. İntravezikal BCG tedavisinin nadir bir komplikasyonu olan granülomatöz orşit olgusu sunuldu.

🔖

Cite This Article

ÇİMEN, S., ALTINTAŞ, R., TAŞDEMİR, C., DAĞLI, A. F. (2014). A Rare Complication of Intravesikal BCG Instillation Which Can Be Confused with Tumour: Granulomatous Orchitis. Van Tıp Dergisi, Cilt: 21 - Sayı: 4, 239–241. https://ajindex.com/articles/334722

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Sylvester RJ, van der MEIJDEN AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002; 168(5):1964-1970.
  2. Herr HW, Schwalb DM, Zhang ZF, Sogani PC, Fair WR, Whitmore WF Jr, et al. Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol 1995; 13(6):1404-1408.
  3. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 1997; 158(1):62-67.
  4. Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WR, Whitmore WF Jr. Superficial bladder cancer treated with bacillus Calmette- Guerin: a multivariate analysis of factors affecting tumor progression. J Urol 1989; 141(1):22-29.
  5. Prescott S, Jackson AM, Hawkyard SJ, Alexandroff AB, James K. Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms. Clin Infect Dis 2000; 31:91-93.
  6. Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol 1986; 135(2):272-274.
  7. Koya MP, Simon MA, Soloway MS. Complications of intravesical therapy for urothelial cancer of the bladder. J Urol 2006; 175(6):2004-2010.
  8. Yusuke H, Yoshinori H, Kenichi M, Akio H. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy. Int J Urol 2006; 13(10):1361-1363.
  9. Falkensammer C, Gozzi C, Hager M, Maier H, Bartsch G, Höltl L, Rehder P. Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma. Urology 2005; 65(1):175. Chung JJ, Kim MJ, Lee T, Yoo HS, Lee JT. Sonographic findings in tuberculous epididymitis and epididymo-orchitis. J Clin Ultrasound 1997; 25(7):390-394.
  10. Kim SH, Pollack HM, Cho KS, Pollack MS, Han MC. Tuberculous epididymitis and epididymo- orchitis: sonographic findings. J Urol 1993; 150(1):81-84.
  11. Salvador R, Vilana R, Bargalló X, Araque X, Nicolau C. Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings. J Ultrasound Med 2007; 26(5):671-674.
  12. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, et al. Cancer mortality in Europe, 2000-2004, and an overview o